Download PDF
Semin Thromb Hemost 2005; 31(1): 85-89
DOI: 10.1055/s-2005-863809
Copyright © 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Learning from Peer Assessment: The Role of the External Quality Assurance Multilaboratory Thrombophilia Test Process

Emmanuel J. Favaloro1
  • 1Senior Scientist in Charge, Haemostasis Laboratories, Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Westmead, New South Wales, Australia
Further Information

Publication History

Publication Date:
11 February 2005 (online)

    Permissions and Reprints

ABSTRACT

The quality control process is a critical feature of pathology best practice. In addition to internal quality control processes applied on a test-to-test or day-to-day basis, the participation of laboratories in external quality assurance programs (QAPs) is critical to achieving ongoing test accuracy. There are several such programs operating in the international arena. With respect to thrombophilia, these include the Australia-based Royal College of Pathologists of Australia QAP, the United Kingdom-based National External Quality Assessment Service, and the International Thrombophilia External Quality Assessment Scheme, based in the Netherlands. Although there are some similarities between the programs, some diversity is also apparent. Each of the programs assess for the common markers of congenital thrombophilia, such as antithrombin, protein C, protein S, and activated protein C resistance. Testing of some acquired markers of thrombophilia, such as lupus anticoagulant, and genetic tests such as factor V Leiden and prothrombin G20210A mutation, are also available. This report focuses on some recent trends from these programs.

KEYWORDS

Protein C - protein S - antithrombin - activated protein C resistance - lupus anticoagulant - laboratory assessment - survey - hemostasis testing - diagnostic practice - quality control

REFERENCES

  • 1 Bertina R M. Genetic approach to thrombophilia.  Thromb Haemost. 2001;  86 92-103
    PubMedGoogle Scholar
  • 2 Simioni P. The molecular genetics of familial venous thrombosis.  Baillieres Best Pract Res Clin Haematol. 1999;  12 479-503
    PubMedGoogle Scholar
  • 3 Thiagarajan P, Shapiro S S. Lupus anticoagulants and antiphospholipid antibodies.  Hematol Oncol Clin North Am. 1998;  12 1167-1192
    CrossrefPubMedGoogle Scholar
  • 4 Van Cott E M, Laposata M. Laboratory evaluation of hypercoagulable states.  Hematol Oncol Clin North Am. 1998;  12 1141-1166
    PubMedGoogle Scholar
  • 5 Rao A K, Kaplan R, Sheth S. Inherited thrombophilic states.  Semin Thromb Hemost. 1998;  24(suppl 1) 3-12
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Field S L, Brighton T A, McNeil H P, Chesterman C N. Recent insights into antiphospholipid antibody-mediated thrombosis.  Baillieres Best Pract Res Clin Haematol. 1999;  12 407-422
    CrossrefPubMedGoogle Scholar
  • 7 Haematology R CPA. QAP contact and program details. Available at: www.rcpaqap.com.au/. Accessed July 20 2004
    Google Scholar
  • 8 UK NEQAS: NEQAS contact and other details. Available at: www.ukneqasbc.org/. Accessed July 20 2004
    Google Scholar
  • 9 ECAT: ECAT contact and other details. Available at: www.ecat.nl/. Accessed July 20 2004
    Google Scholar
  • 10 CAP: CAP contact and other details. Available at: www.cap.org/apps/cap.portal. Accessed July 20 2004
    Google Scholar
  • 11 Favaloro E J, Smith J, Petinos P, Collecutt M, Street A, Hertzberg M. on behalf of the RCPA Quality Assurance Program (QAP) in Haematology Scientific Haemostasis Advisory Panel . Laboratory testing, diagnosis and management of von Willebrand's disease: Current practice in Australasia.  Am J Clin Pathol. 1999;  112 712-719
    PubMedGoogle Scholar
  • 12 Favaloro E J, Smith J, Petinos P, Hertzberg M, Koutts J. on behalf of the RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel . Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey.  Thromb Haemost. 1999;  82 1276-1282
    PubMedGoogle Scholar
  • 13 Favaloro E J, Thom J, Baker R. on behalf of the Australasian Society for Thrombosis and Haemostasis Emerging Technologies Group . Assessment of current diagnostic practice and efficacy in testing for von Willebrand's disease: Results from the second Australasian laboratory survey.  Blood Coagul Fibrinolysis. 2000;  11 729-738
    CrossrefPubMedGoogle Scholar
  • 14 Favaloro E J, Bonar R, Sioufi J et al.. Laboratory diagnosis of von Willebrand Disorder: current practice in the Southern Hemisphere.  Am J Clin Pathol. 2003;  119 882-893
    CrossrefPubMedGoogle Scholar
  • 15 Favaloro E J, Bonar R, Kershaw G et al.. Laboratory diagnosis of von Willebrand's disorder: quality and diagnostic improvements driven by peer review in a multi-laboratory test process.  Haemophilia. 2004;  10 232-242
    CrossrefPubMedGoogle Scholar
  • 16 Favaloro E J, Bonar R, Sioufi J et al.. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Haematology Quality Assessment Program.  Semin Thromb Hemost. 2005;  31 49-58
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Favaloro E J, Wong R, Silvestrini R, McEvoy R, Jovanovich S, Roberts-Thompson P. A multilaboratory peer assessment quality assurance program-based evaluation of anticardiolipin antibody and beta2-glycoprotein I antibody testing.  Semin Thromb Hemost. 2005;  31 73-84
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Hertzberg M, McDonald D, Neville S, Favaloro E J. External quality assurance of DNA testing for thrombophilic mutations. Am J Clin Pathol 2005 (in press)
    Google Scholar
  • 19 Jennings I, Kitchen S, Woods T AL, Preston F E, Greaves M. Clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK NEQAS for Blood Coagulation.  Thromb Haemost. 1997;  77 934-937
    PubMedGoogle Scholar
  • 20 Preston F E, Kitchen S, Jennings I, Woods T A. A UK National External Quality Assessment scheme (UK NEQAS) for molecular genetic testing for the diagnosis of familial thrombophilia.  Thromb Haemost. 1999;  82 1556-1557
    PubMedGoogle Scholar
  • 21 Jennings I, Kitchen S, Woods T A, Preston F E. Normalization does not improve between-laboratory agreement but may improve specificity of some assays for activated protein C resistance.  Blood Coagul Fibrinolysis. 1999;  10 451-453
    PubMedGoogle Scholar
  • 22 Jennings I, Kitchen S, Cooper P C, Rimmer J E, Woods T A, Preston F E. Further evidence that activated protein C resistance affects protein C coagulant activity assays.  Thromb Haemost. 2000;  83 171-172
    PubMedGoogle Scholar
  • 23 Jennings I, Greaves M, Mackie I J, Kitchen S, Woods T A, Preston F E. UK National External Quality Assessment Scheme for Blood Coagulation. Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods.  Br J Haematol. 2002;  119 364-369
    CrossrefPubMedGoogle Scholar
  • 24 Jennings I, Kitchen S, Smith J, Woods T A, Preston F E. Between-centre agreement in homocysteine assays: experience from the UK NEQAS proficiency testing scheme.  Thromb Haemost. 2002;  87 921-922
    PubMedGoogle Scholar
  • 25 Jennings I, Kitchen S, Cooper P, Makris M, Preston F E. Sensitivity of functional protein S assays to protein S deficiency: a comparative study of three commercial kits.  J Thromb Haemost. 2003;  1 1112-1114
    CrossrefPubMedGoogle Scholar
  • 26 Jennings I, Kitchen S, Woods T AL, Preston F E. Multilaboratory testing in thrombophilia through the United Kingdom National External Quality Assessment Service (Blood Coagulation) Quality Assurance Program.  Semin Thromb Hemost. 2005;  31 66-72
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Meijer P, De Maat M PM, Kluft C, Haverkate F, Van Houwelingen H C. Assessment of the long-term analytical performance of field methods in haemostasis by evaluation of results of an external quality assessment programme.  Clin Chem. 2002;  48 1011-1015
    PubMedGoogle Scholar
  • 28 Meijer P, Kluft C, Haverkate F, De Maat M P. The long-term within- and between-laboratory variability for assay of antithrombin, and proteins C and S: results derived from the external quality assessment program for thrombophilia screening of the ECAT Foundation.  J Thromb Haemost. 2003;  1 748-753
    CrossrefPubMedGoogle Scholar
  • 29 Meijer P, Haverkate F. External quality assessment and the laboratory diagnosis of thrombophilia.  Semin Thromb Hemost. 2005;  31 59-65
    Article in Thieme ConnectPubMedGoogle Scholar
  • 30 Favaloro E J, Orsag I, Bukuya M, McDonald D. A nine-year retrospective assessment of laboratory testing for activated protein C resistance: Evolution of a novel approach to thrombophilia investigations.  Pathology. 2002;  34 348-355
    CrossrefPubMedGoogle Scholar
  • 31 Favaloro E J, Mirochnik O, McDonald D. Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with RVVT- than APTT-based assays.  Br J Biomed Sci. 1999;  56 23-33
    PubMedGoogle Scholar
  • 32 Favaloro E J, Silvestrini R, Mohammed A. Clinical utility of anticardiolipin antibody assays: high inter-laboratory variation and limited consensus by participants of external Quality Assurance Programs signals a cautious approach.  Pathology. 1999;  31 142-147
    CrossrefPubMedGoogle Scholar
  • 33 Favaloro E J, Silvestrini R. Assessing the utility of anticardiolipin antibody assays: a cautious approach is suggested by high variation and limited consensus in multi-laboratory testing.  Am J Clin Pathol. 2002;  118 548-557
    CrossrefPubMedGoogle Scholar
  • 34 Tincani A, Allegri F, Sanmarco M et al.. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations: a cooperative project of the European Antiphospholipid Forum.  Thromb Haemost. 2001;  86 575-583
    PubMedGoogle Scholar
  • 35 Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature.  Blood. 2003;  101 1827-1832
    CrossrefPubMedGoogle Scholar
  • 36 Galli M, Barbui T. Antiphospholipid syndrome: clinical and diagnostic utility of laboratory tests.  Semin Thromb Hemost. 2005;  31 17-24
    Article in Thieme ConnectPubMedGoogle Scholar
  • 37 Lutz C T, Foster P A, Noll W W et al.. Multicenter evaluation of PCR methods for the detection of factor V Leiden (R506Q) genotypes.  Clin Chem. 1998;  44 1356-1358
    PubMedGoogle Scholar
  • 38 Tripodi A, Peyvandi F, Chantarangkul V, Menegatti M, Mannucci P M. Relatively poor performance of clinical laboratories for DNA analyses in the detection of two thrombophilic mutations-a cause for concern.  Thromb Haemost. 2002;  88 690-691
    PubMedGoogle Scholar
  • 39 Favaloro E J. Diagnostic issues in thrombophilia: a laboratory scientist's view.  Semin Thromb Hemost. 2005;  31 11-16
    Article in Thieme ConnectPubMedGoogle Scholar

 Dr.
E. J Favaloro

Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR)

WSAHS, Westmead, New South Wales, 2145, Australia

Email: emmanuel@icpmr.wsahs.nsw.gov.au

      >